Polymorphism in the promoter region of the klotho gene (G-395A) is associated with early dysfunction in vascular access in hemodialysis patients

Korean Journal of Internal Medicine

Volumn 23, Issue 4, 2008, Pages 201-207

  Kim, Youngsu ^a   Jeong, Sun Joo ^a   Lee, Hyung Suk ^b   Kim, Eun Jung ^a,b   Song, Young Rim ^a,b   Kim, Sung Gyun ^a,b   Oh, Ji Eun ^a,b   Lee, Young Ki ^a,b   Seo, Jang Won ^a,b   Yoon, Jong Woo ^a,b   Koo, Ja Ryong ^a,b   Kim, Hyung Jik ^a,b   Noh, Jung Woo ^a,b   Park, Seung Ho ^c  

^a Hallym University College of Medicine   (South Korea)

^b Hallym Kidney Research Institute   (South Korea)

^c Department of Internal Medicine   (South Korea)

Author keywords

Arteriovenous access; Hemodialysis; Klotho

Indexed keywords

ADULT; AGED; ALLELE; ARTERIOSCLEROSIS; ARTICLE; ENDOTHELIAL DYSFUNCTION; FEMALE; GENE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; KLOTHO GENE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK FACTOR; THROMBOSIS; VASCULAR ACCESS; ARTERIOVENOUS SHUNT; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; GENETICS; INDWELLING CATHETER; MIDDLE AGED; RENAL REPLACEMENT THERAPY; VASCULAR DISEASE; VASCULAR PATENCY;

BETA GLUCURONIDASE; KLOTHO PROTEIN;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; COHORT STUDIES; FEMALE; GLUCURONIDASE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RENAL DIALYSIS; VASCULAR DISEASES; VASCULAR PATENCY;

EID: 63249103864     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2008.23.4.201     Document Type: Article

References (27)

1. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 7:523-535, 1996
2. Woods JD, Port FK. The impact of vascular access for haemodialysis on patient morbidity and mortality. Nephrol Dial Transplant 12:657-659, 1997 (Pubitemid 27170415)
3. Zibari GB, Rohr MS, Landreneau MD, Bridges RM, DeVault GA, Petty FH, Costley KJ, Brown ST, McDonald JC. Complication from permanent hemodialysis vascular access. Surgery 104:681-686, 1988 (Pubitemid 18238747)
4. Palder SB, Kirkman RL, Whittemore AD, Hakim RM, Lazarus JM, Tilney NL. Vascular access for hemodialysis: patency rates and results of revision. Ann Surg 202:235-239, 1985
5. Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A. Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg 12:207-213, 1996 (Pubitemid 26293579)
6. Moon SY, Park BJ, Lee HI, Jeong KH, Kim JH, Lee SH, Lee TW, Ihm CG, Kim MJ. Risk factors for early access failure of arteriovonous fistula in hemodialysis patients. Korean J Nephrol 25:423-429, 2006
7. Kim YO, Yoon SA, Kim YS, Kim MK, Oh HJ, Ku YM, Song HH, Kim KT, Chang YS, Bang BK. Early dysfunction of radiocephalic arterioveonus fistula: primary and secondary patency rate of percutaneous angioplasty. Korean J Nephrol 22:414-419, 2003
8. Kim YO, Yang CW, Yoon SA, Chun KA, Kim NI, Park JS, Kim BS, Kim YS, Chang YS, Bang BK. Access blood flow as a predictor of early failures of native arteriovenous fistulas in hemodialysis patients. Am J Nephrol 21:221-225, 2001
9. De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 7:1169-1177, 1996 (Pubitemid 27468269)
10. Girndt M, Heine GH, Ulrich C, Kohler H. Gene polymorphism association studies in dialysis: vascular access. Semin Dial 20:63-67, 2007
11. Kim YO, Song HC, Yoon SA, Kim YS, Yang CW, Lee SH, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK. The impact of ischemic heart disease on early arteriovenous fistula failure in nondiabetic hemodialysis patients. Korean J Nephrol 23:101-107, 2004
12. Kim YO. Hemodialysis vascular accss dysfunction: a cellular and molecular viewpoint. Korean J Nephrol 25(Suppl):S559-S562, 2006
13. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M. Suppression of aging in mice by the hormone Klotho. Science 309:1829-1833, 2005
14. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45-51, 1997 (Pubitemid 27494749)
15. Arking DE, Atzmon G, Arking A, Barzilai N, Dietz HC. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res 96:412-418, 2005 (Pubitemid 40354534)
16. Arking DE, Becker DM, Yanek LR, Fallin D, Judge DP, Moy TF, Becker LC, Dietz HC. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet 72:1154-1161, 2003 (Pubitemid 36530003)
17. Rhee EJ, Kim SY, Jung CH, Kim BJ, Sung KC, Kim BS, Lee WY, Kang JH, Oh KW, Lee MH, Kim SW, Park JR. The association of KLOTHO gene polymorphism with coronary artery disease in Korean subjects. Korean J Med 70:268-276, 2006
18. Kim Y, Kim JH, Nam YJ, Kong M, Kim YJ, Yu KH, Lee BC, Lee C. Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females. Neurosci Lett 407:189-194, 2006 (Pubitemid 44402870)
19. Kawano K, Ogata N, Chiano M, Molloy H, Kleyn P, Spector TD, Uchida M, Hosoi T, Suzuki T, Orimo H, Inoue S, Nabeshima Y, Nakamura K, Kuro-o M, Kawaguchi H. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res 17:1744-1751, 2002
20. Nagai R, Saito Y, Ohyama Y, Aizawa H, Suga T, Nakamura T, Kurabayashi M, Kuro-o M. Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases. Cell Mol Life Sci 57:738-746, 2000 (Pubitemid 30392032)
21. Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276:767-772, 2000
22. Takeshita K, Yamamoto K, Ito M, Kondo T, Matsushita T, Hirai M, Kojima T, Nishimura M, Nabeshima Y, Loskutoff DJ, Saito H, Murohara T. Increased expression of plasminogen activator inhibitor-1 with fibrin deposition in a murine model of aging, "Klotho" mouse. Semin Thromb Hemost 28:545-554, 2002
23. Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ. Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis 36:1126-1134, 2000
24. Ernandez T, Saudan P, Berney T, Merminod T, Bednarkiewicz M, Martin PY. Risk factors for early failure of native arteriovenous fistulas. Nephron Clin Pract 101:C39-C44, 2005 (Pubitemid 41159943)
25. De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 7:1169-1177, 1996 (Pubitemid 27468269)
26. Deary IJ, Harris SE, Fox HC, Hayward C, Wright AF, Starr JM, Whalley LJ. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci Lett 378:22-27, 2005 (Pubitemid 40341936)
27. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet 38:218-222, 2006 (Pubitemid 43177237)